Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.7K Buy
292
+76
+35% +$6.13K ﹤0.01% 360
2026
Q1
$15.3K Buy
216
+93
+76% +$6.96K ﹤0.01% 401
2025
Q4
$9.71K Buy
+123
New +$9.73K ﹤0.01% 431
2018
Q2
Sell
-200
Closed -$9K 361
2018
Q1
$9K Hold
200
﹤0.01% 282
2017
Q4
$10K Hold
200
﹤0.01% 288
2017
Q3
$10K Sell
200
-24
-11% -$1.17K 0.01% 244
2017
Q2
$11K Hold
224
0.01% 259
2017
Q1
$11K Hold
224
0.01% 284
2016
Q4
$11K Buy
+224
New +$10.3K 0.01% 287

Other funds holding MET

Trust Company's MET Position: Q2 2026 in Review

Trust Company increased its MetLife (MET) stake by 35% in Q2 2026, buying an estimated $6.13K and bringing the position to 292 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Trust Company first reported a position in MET in Q4 2016 and has held it in 9 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Trust Company held 292 shares of MetLife worth $24.7K as of Q2 2026.
  • Trust Company bought 76 MetLife shares in Q2 2026, an estimated $6.13K.
  • MetLife made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #360 holding.
  • Trust Company first reported a position in MetLife in Q4 2016 and has held it in 9 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.